Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
- Lancet Oncol., Volume 21, Issue 12, December 2020, Pages 1653-1660 | https://doi.org/10.1016/S1470-2045(20)30486-1